Long-circulating liposomal contrast agents for magnetic resonance imaging

Magnetic Resonance in Medicine

Volumn 55, Issue 5, 2006, Pages 1023-1029

  Ayyagari, Ananta Laxmi ^a   Zhang, Xiaodong ^a,d   Ghaghada, Ketan B ^b,c   Annapragada, Ananth ^c   Hu, Xiaoping ^a,d   Bellamkonda, Ravi V ^a,e  

^a EMORY UNIVERSITY   (United States)

^b University of Houston   (United States)

^c UNIVERSITY OF TEXAS   (United States)

^d Georgia State University   (United States)

^e EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHELATION; GADOLINIUM; LIPOSOMES;

CONTRAST AGENT; CONTRAST ENHANCEMENT; CONTRAST-ENHANCED; DYNAMIC TECHNIQUES; HIGH SPATIAL RESOLUTION; LIPOSOMAL FORMULATION; LONG CIRCULATING; RAPID DIFFUSION;

MAGNETIC RESONANCE IMAGING;

CONTRAST MEDIUM; GADODIAMIDE; GADOLINIUM PENTETATE; LIPID; LIPOSOME; MACROGOL;

ANIMAL EXPERIMENT; ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DRUG DIFFUSION; DRUG FORMULATION; ENCAPSULATION; IMAGE ANALYSIS; MAGNETIC RESONANCE ANGIOGRAPHY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; RAT; STEADY STATE;

EID: 33646457646     PISSN: 07403194     EISSN: 15222594     Source Type: Journal    
DOI: 10.1002/mrm.20846     Document Type: Article

References (37)

1. Kobayshi H, Sato N, Kawamoto S, Saga T, Hiraga A, Ishimori T, Konishi J, Togashi K, Brechbiel MW. 3D MR angiography of mice using macromolecular MR contrast agents with polyamindoamine dendrimer core with reference to their pharmacokinetic properties. Magn Reson Med 2001;45:454-460.
2. Prince MR. Body MR angiography with gadolinium contrast agents. Magn Reson Imaging Clin N Am 1996;4:11-24.
3. Bogdanov Jr AA, Lewin M, Weissleder R. Approaches and agents for imaging the vascular system. Adv Drug Deliv Rev 1999;37:279-293.
4. Lauffer, RB, Parmelee DJ, Dunham SU, Quellet HS, Dolan RP, Witte S, McMurry TJ, Walovitch RC. MS-325: albumin-targeted contrast agent for MR angiography. Radiology 1998;207:529-538.
5. Adam G, Neuerburg J, Spuntrup E, Muhler A, Scherer K, Gunther RW. Gd-DTPA-cascade-polymer: potential blood pool contrast agent for MR imaging. J Magn Reson Imaging 1994;4:462-466.
6. Bogdanov AA, Weissleder R, Frank HW, Bogdanova AV, Nossif N, Schaffer BK, Tsai E, Papisov MI, Brady TJ. A new macromolecule as a contrast agent for MR angiography: preparation, properties, and animal studies. Radiology 1993;187:701-706.
7. Frank H, Weissleder R, Brady TJ. Enhancement of MR angiography with iron oxide: preliminary studies in whole-blood phantom and in animals. AJR Am J Roentgenol 1994;162:209-213.
8. Loubeyre P, Zhao S, Canet E, Abidi H, Benderbous S, Revel D. Ultrasmall superparamagnetic iron oxide particles (AMI 227) as a blood pool contrast agent for MR angiography: experimental study in rabbits. J Magn Reson Imaging 1997;7:958-962.
9. Wallace RA, Haar Jr JP, Miller DB, Woulfe SR, Polta JA, Galen KP, Hynes MR, Adzamli K. Synthesis and preliminary evaluation of MP-2269: a novel, nonaromatic small-molecule blood-pool MR contrast agent. Magn Reson Med 1998;40:733-739.
10. Anzai Y, Prince MR, Chenevert TL, Maki JH, Londy F, London M, McLachlan SJ. MR angiography with an ultrasmall superparamagnetic iron oxide blood pool agent. J Magn Reson Imaging 1997;7:209-214.
11. Saeed M, Wendland MF, Higgins CB. Blood pool MR contrast agents for cardiovascular imaging. J Magn Reson Imaging 2000;12:890-898.
12. Joarder R, Gedroyc WM. Magnetic resonance angiography: the state of art. Eur Radiol 2001;11:446-453.
13. 15-20: whole body clearance, plasma clearance and organ distribution of gadolinium. In: Proceedings of the Annual Meeting of SMRM, Berkeley, CA, USA, 1989. p 807.
14. Adam G, Neuerburg J, Spuntrup E, Muhler A, Scherer K, Gunther RW. Dynamic contrast-enhanced MR imaging of the upper abdomen: enhancement properties of gadobutrol, gadolinium-DTPA-polylysine, and gadolinium-DTPA-cascade-polymer. Magn Reson Med 1994;32:622-628.
15. Moseley ME, White DL, Wang SC. Vascular mapping using albumin-(Gd-DTPA), an intravascular MR contrast agent, and projection MR imaging. J Comput Assist Tomogr 1988;13:215-221.
16. Bourne MW, Margerun L, Hylton N, Campion B, Lai JJ, Derugin N, Higgins CB. Evaluation of the effects of intravascular MR contrast media (gadolinium dendrimer) on 3D time of flight magnetic resonance angiography of the body. J Magn Reson Imaging 1996;6:305-310.
17. Grist TM, Korosec FR, Peters DC, Witte S, Walovitch RC, Dolan RP, Bridson WE, Yucel EK, Mistretta CA. Steady-state and dynamic MR angiography with MS-325: initial experience in humans. Radiology 1998;207:539-544.
18. Brasch R, Turetschek K. MRI characterization of tumors and grading angiogenesis using macromolecular contrast media: status report. Eur J Radiol 2000;34:148-155.
19. Claude BS, David RV, Jacquelin AC, Marlon BC, Richard BB, Rober FM. Gadolinium-DTPA-dextran: a macromolecular MR blood pool contrast agent. Acad Radiol 2004;11:1361-1369.
20. Taylor AM, Panting JR, Keegan J, Gatehouse PD, Jhooti P, Yang GZ, McGill S, Francis JM, Burman ED, Firmin DN, Pennell DJ. Safety and preliminary findings with the intravascular contrast agent NC100150 injection for MR coronary angiography. J Magn Reson Imaging 1999;9:220-227.
21. Engelbrecht MR, Saeed M, Wendland MF, Canet E, Oksendal AN, Higgins CB. Contrast-enhanced 3D-TOF MRA of peripheral vessels: intravascular versus extracellular MR contrast media. J Magn Reson Imaging 1998;8:616-621.
22. Allen TM, Hansen C, Martin F, Redemann C, Yau-Young A. Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation halflives in vivo. Biochim Biophys Acta 1991;1066:29-36.
23. Tilcock C, Unger E, Cullis P, MacDougall P. Liposomal Gd-DTPA: preparation and characterization of relaxivity. Radiology 1989;171:77-80.
24. Tilcock C, MacDougall P, Unger E, Cardenas D, Fajardo L. The effect of lipid composition on the relaxivity of Gd-DTPA entrapped in lipid vesicles of defined size. Biochim Biophys Acta 1990;1022:181-186.
25. Fossheim SL, Colet JM, Mansson S, Fahlvik AK, Muller RN, Klaveness J. Paramagnetic liposomes as magnetic resonance imaging contrast agents. Assessment of contrast efficacy in various liver models. Invest Radiol 1998;33:810-821.
26. Unger EC, MacDougall P, Cullis P, Tilcock C. Liposomal Gd-DTPA: effect of encapsulation on enhancement of hepatoma model by MRI. Magn Reson Imaging 1989;7:417-423.
27. Fujimoto Y, Okuhata Y, Tyngi S, Namba Y, Oku N. Magnetic resonance lymphography of profundus lymph nodes with liposomal gadolinium- diethylenetriamine pentaacetic acid. Biol Pharm Bull 2000;23:97-100.
28. Trabetskoy VS, Cannillo JA, Milshtein A, Wolf GL, Torchilin VP. Controlled delivery of Gd-containing liposomes to lymph nodes: surface modification may enhance MRI contrast properties. Magn Reson Imaging 1995;13:31-37.
29. Saito R, Bringas JR, McKnight TR, Wendland MF, Mamot C, Drummond DC, Kirpotin DB, Park JW, Berger MS, Bankiewicz KS. Distribution of liposomes into brain and rat brain tumor models by convection-enhanced delivery monitored with magnetic resonance imaging. Cancer Res 2004;64:2572-2579.
30. Fritz T, Unger E, Wilson-Sanders S, Ahkong QF, Tilcock C. Detailed toxicity studies of liposomal gadolinium-DTPA. Invest Radiol 1991;26:960-968.
31. Grunder W, Biesold M, Wagner M, Werner A. Improved nuclear magnetic resonance microscopic visualization of joint cartilage using liposome entrapped contrast agents. Invest Radiol 1998;33:193-202.
32. Heverhagen JT, Graser A, Fahr A, Muller R, Alfke H. Encapsulation of gadobutrol in AVE-based liposomal carriers for MR detectability. Magn Reson Imaging 2004;22:483-487.
33. Lokling KE, Skurtveit R, Dyrstad K, Klaveness J, Fossheim SL. Tuning the MR properties of blood-stable pH-responsive paramagnetic liposomes. Int J Pharm 2004;274:75-83.
34. Unger E, Needleman P, Cullis P, Tilcock C. Gadolinium-DTPA liposomes as a potential MRI contrast agent. Work in progress. Invest Radiol 1988;23:928-932.
35. Weissig VV, Babich J, Torchilin VV. Long-circulating gadolinium-loaded liposomes: potential use for magnetic resonance imaging of the blood pool. Colloids Surf B Biointerfaces 2000;18:293-299.
36. Storrs RW, Tropper FD, Li HY, Song CK, Sipkins DA, Kuniyoshi JK, Bednarski MD, Strauss HW, Li KC. Paramagnetic polymerized liposomes as new recirculating MR contrast agents. J Magn Reson Imaging 1995;5:719-724.
37. Gabizon A, Huang A, Martin F, Berenholz Y. Doxorubicin encapsulated in polyethylene-glycol coated liposomes: initial clinical-pharmacokinetic studies in solid tumors. In: Lasic D, Martin F, editors. Stealth liposomes. Boca Raton, FL: CRC Press, Inc.: 1995. p 245-255.